Literature DB >> 33628758

Metabolic and Hepatic Effects of Energy-Reduced Anti-Inflammatory Diet in Younger Adults with Obesity.

Gordana Kenđel Jovanović1, Ines Mrakovcic-Sutic2,3, Sandra Pavičić Žeželj1,4, Indira Benjak Horvat5, Lucia Šuša6, Dario Rahelić7,8,9, Sanja Klobučar Majanović10,11.   

Abstract

Background: Associated with epidemics of obesity, nonalcoholic fatty liver disease (NAFLD) is becoming the most prevalent liver disease worldwide. The cornerstone of therapy for NAFLD is lifestyle intervention, mainly focused on weight loss. Significant weight loss results from energy-restricted diets, regardless of macronutrient distribution. An anti-inflammatory diet was related to lower odds of NAFLD among daily alcohol drinkers and individuals with metabolic syndrome. This study aims to evaluate the effect of an energy-reduced anti-inflammatory diet on liver status in younger adults with obesity after a 6-month follow-up.
Methods: A two-arm randomized controlled trial surveyed 81 participants' (mean age, 43 years) anthropometric and body composition changes. Metabolic status was determined with glycaemic and lipid status, inflammatory status with hs-CRP, IL-6, and TNF-α, and liver status with liver enzymes, NAFLD-FLS, FLI, and FIB-4 indices. The inflammatory potential of the diet was assessed by the Dietary Inflammatory Index, DII®.
Results: Energy-restricted anti-inflammatory diet resulted in significant weight loss (-7.1%, p < 0.001), in reducing the visceral adiposity (-22.3%, p < 0.001), metabolic (HOMA-IR, -15.5%; total cholesterol, -5.3%; LDL-C, -4.6%; triglycerides, -12.2%), and inflammatory biomarkers (hs-CRP, -29.5%; IL-6, -18.2%; TNF-α, -34.2%), with significant improvement of liver parameters (NAFLD-FLS, -143.4%; FLI, -14.3%; FIB-4, -2.5%).
Conclusion: The study showed the effectiveness of the anti-inflammatory diet with significant improvement of liver parameters in younger adults with obesity, which may reinforce the effectiveness of nutrition-based lifestyle programs, with an anti-inflammatory dietary approach for the treatment and resolution of NAFLD.
Copyright © 2021 Gordana Kenđel Jovanović et al.

Entities:  

Year:  2021        PMID: 33628758      PMCID: PMC7886596          DOI: 10.1155/2021/6649142

Source DB:  PubMed          Journal:  Can J Gastroenterol Hepatol        ISSN: 2291-2789


  46 in total

Review 1.  Impact of current treatments on liver disease, glucose metabolism and cardiovascular risk in non-alcoholic fatty liver disease (NAFLD): a systematic review and meta-analysis of randomised trials.

Authors:  G Musso; M Cassader; F Rosina; R Gambino
Journal:  Diabetologia       Date:  2012-01-27       Impact factor: 10.122

Review 2.  Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics.

Authors:  Stergios A Polyzos; Jannis Kountouras; Christos S Mantzoros
Journal:  Metabolism       Date:  2018-11-29       Impact factor: 8.694

3.  Weight loss is a critical factor to reduce inflammation.

Authors:  Vittorio Emanuele Bianchi
Journal:  Clin Nutr ESPEN       Date:  2018-09-03

4.  Association of Pro-inflammatory Dietary Intake and Non-Alcoholic Fatty Liver Disease: Findings from Iranian case-control study.

Authors:  Farhad Vahid; Nitin Shivappa; Azita Hekmatdoost; James R Hebert; Hossein Poustchi; Ali Shamsipour; Tannaz Eslamparast; Mohammad Meibodi; Diyako Rahmani
Journal:  Int J Vitam Nutr Res       Date:  2019-03-19       Impact factor: 1.784

Review 5.  Lifestyle interventions for the treatment of non-alcoholic fatty liver disease in adults: a systematic review.

Authors:  Christian Thoma; Christopher P Day; Michael I Trenell
Journal:  J Hepatol       Date:  2011-07-01       Impact factor: 25.083

Review 6.  Non-pharmacological interventions in non-alcoholic fatty liver disease patients.

Authors:  Vlad Ratziu
Journal:  Liver Int       Date:  2017-01       Impact factor: 5.828

7.  Validity and repeatability of a simple index derived from the short physical activity questionnaire used in the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Authors:  Nicholas J Wareham; Rupert W Jakes; Kirsten L Rennie; Jantine Schuit; Jo Mitchell; Susie Hennings; Nicholas E Day
Journal:  Public Health Nutr       Date:  2003-06       Impact factor: 4.022

8.  Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction.

Authors:  Erik Kirk; Dominic N Reeds; Brian N Finck; S Mitra Mayurranjan; Mitra S Mayurranjan; Bruce W Patterson; Samuel Klein
Journal:  Gastroenterology       Date:  2009-01-25       Impact factor: 22.682

9.  Prediction of non-alcoholic fatty liver disease and liver fat using metabolic and genetic factors.

Authors:  Anna Kotronen; Markku Peltonen; Antti Hakkarainen; Ksenia Sevastianova; Robert Bergholm; Lina M Johansson; Nina Lundbom; Aila Rissanen; Martin Ridderstråle; Leif Groop; Marju Orho-Melander; Hannele Yki-Järvinen
Journal:  Gastroenterology       Date:  2009-06-12       Impact factor: 22.682

10.  Comparison of liver fat indices for the diagnosis of hepatic steatosis and insulin resistance.

Authors:  Sabine Kahl; Klaus Straßburger; Bettina Nowotny; Roshan Livingstone; Birgit Klüppelholz; Kathrin Keßel; Jong-Hee Hwang; Guido Giani; Barbara Hoffmann; Giovanni Pacini; Amalia Gastaldelli; Michael Roden
Journal:  PLoS One       Date:  2014-04-14       Impact factor: 3.240

View more
  4 in total

Review 1.  The Effect of Dietary Interventions on Hypertriglyceridemia: From Public Health to Molecular Nutrition Evidence.

Authors:  Karla Paulina Luna-Castillo; Xochitl Citlalli Olivares-Ochoa; Rocío Guadalupe Hernández-Ruiz; Iris Monserrat Llamas-Covarrubias; Saraí Citlalic Rodríguez-Reyes; Alejandra Betancourt-Núñez; Barbara Vizmanos; Erika Martínez-López; José Francisco Muñoz-Valle; Fabiola Márquez-Sandoval; Andres López-Quintero
Journal:  Nutrients       Date:  2022-03-05       Impact factor: 5.717

2.  Relationship between Low Vegetable Consumption, Increased High-Sensitive C-Reactive Protein Level, and Cardiometabolic Risk in Korean Adults with Tae-Eumin: A Cross-Sectional Study.

Authors:  Jieun Kim; Kyoungsik Jeong; Siwoo Lee; Younghwa Baek
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-11       Impact factor: 2.629

Review 3.  Nonalcoholic Fatty Liver Disease: Focus on New Biomarkers and Lifestyle Interventions.

Authors:  Maria Notarnicola; Alberto Ruben Osella; Maria Gabriella Caruso; Pasqua Letizia Pesole; Antonio Lippolis; Valeria Tutino; Caterina Bonfiglio; Valentina De Nunzio; Maria Principia Scavo; Antonella Mirizzi; Isabella Franco; Tamara Lippolis; Rosalba D'Alessandro; Maria Grazia Refolo; Caterina Messa
Journal:  Int J Mol Sci       Date:  2021-04-09       Impact factor: 5.923

4.  Curcumin Offers No Additional Benefit to Lifestyle Intervention on Cardiometabolic Status in Patients with Non-Alcoholic Fatty Liver Disease.

Authors:  Kaveh Naseri; Saeede Saadati; Zahra Yari; Behzad Askari; Davood Mafi; Pooria Hoseinian; Omid Asbaghi; Azita Hekmatdoost; Barbora de Courten
Journal:  Nutrients       Date:  2022-08-06       Impact factor: 6.706

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.